⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MSLE News
Satellos Bioscience Inc. Common Stock
Satellos Reports First Quarter 2026 Financial Results and Highlights Company Progress
globenewswire.com
MSLE
Satellos to Present at the Bloom Burton & Co. Healthcare Investor Conference
globenewswire.com
MSLE
Satellos Reports 2025 Financial Results and Highlights Recent Company Progress
globenewswire.com
MSLE
Satellos Presents Interim SAT-3247 Clinical and Biomarker Data in Duchenne Muscular Dystrophy at the 2026 MDA Clinical & Scientific Conference
globenewswire.com
MSLE
Satellos Announces Upcoming Oral and Poster Presentations at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference
businesswire.com
MSLE
Satellos to Host Virtual KOL Event on SAT-3247 in Duchenne Muscular Dystrophy
businesswire.com
MSLE
Satellos to Host Virtual KOL Event on SAT-3247 in Duchenne Muscular Dystrophy
businesswire.com
MSLE
Satellos to Participate in Upcoming Investor Conferences
businesswire.com
MSLE
Satellos to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit 2026
businesswire.com
MSLE
Satellos Closes US$57.2 Million Public Offering in Canada and the United States, Including Exercise of Underwriters’ Option to Purchase Additional Shares
businesswire.com
MSLE